Managing T2DM in Patient with Inadequate Glycemic Control on Low Dose Metformin
Recent studies have shown that combination therapy with glimepiride/metformin offers significant advantages over metformin up-titration alone in reducing glycated hemoglobin (HbA1c) levels.
Considering the available options for treating type 2 diabetic patients, which treatment approach would you prefer to reduce glycated hemoglobin (HbA1c) levels?
No comments:
Post a Comment